Product Name | D-LAP5.Na |
Description |
NMDA receptor antagonist |
Purity | >99.0 |
CAS No. | 1303993-72-7 |
Molecular Formula | C5H12NO5P•Na |
Molecular Weight | 219.11 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Antagonist |
Solubility | Soluble to 100 mM in water |
Source | Synthetic |
Appearance | White solid |
SMILES | C([P](O)(O)=O)CCC(C(O)=O)N |
Safety Phrases |
Classification: Not WHMIS controlled. Safety Phrases: S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. |
Cite This Product | D-LAP5.Na (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-414) |
Alternative Names | DL-amino-5-phosphonopentaoic acid sodium salt |
Research Areas | Glutamate Receptors, Ion Channels, Neuroscience, Neurotransmitter Receptors, NMDA Receptors |
Scientific Background | DLAP5 is a racemic mixture. It is used widely as a potent and selective NMDA receptor antagonist. It represents the active enantiomer form of AP5 (2-amino-5-phosphonopentanoic acid). |
References |
1. Davies J., & Watkins J. (1982) Brain Res. 378-86. 2. Schulte M., Roon R., Chalmers D., Sunter D., & Koerner J. (1994) Brain Res. 203-7. |
Reviews
There are no reviews yet.